ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“ESMOAI26: Artificial intelligence is rapidly transforming oncology research and clinical practice.
ESMO AI and Digital Oncology Congress 2026: Abstracts
Submit your abstract and join leading experts exploring technological advances, multidisciplinary collaboration, ethical and regulatory frameworks, and responsible AI implementation in cancer care.
If you are working on abstracts on the following topics, then this is the right platform for you:
- AI in cancer care
- Digital health solutions
- Ethics and regulation
- Human-AI interaction
- Real-world implementation
Submit your abstract by 1 September 2026.”
Other articles about ESMO on OncoDaily.